DE68927348D1 - Künstlicher impfstoff gegen aids-virus - Google Patents
Künstlicher impfstoff gegen aids-virusInfo
- Publication number
- DE68927348D1 DE68927348D1 DE68927348T DE68927348T DE68927348D1 DE 68927348 D1 DE68927348 D1 DE 68927348D1 DE 68927348 T DE68927348 T DE 68927348T DE 68927348 T DE68927348 T DE 68927348T DE 68927348 D1 DE68927348 D1 DE 68927348D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccine against
- aids virus
- against aids
- artificial
- artificial vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000016784 immunoglobulin production Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/222,684 US5030449A (en) | 1988-07-21 | 1988-07-21 | Synthetic vaccine against AIDS virus |
PCT/US1989/003123 WO1990000901A1 (en) | 1988-07-21 | 1989-07-19 | Synthetic vaccine against aids virus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68927348D1 true DE68927348D1 (de) | 1996-11-21 |
DE68927348T2 DE68927348T2 (de) | 1997-02-13 |
Family
ID=22833252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68927348T Expired - Fee Related DE68927348T2 (de) | 1988-07-21 | 1989-07-19 | Künstlicher impfstoff gegen aids-virus |
Country Status (9)
Country | Link |
---|---|
US (1) | US5030449A (de) |
EP (1) | EP0429477B1 (de) |
JP (1) | JP2676166B2 (de) |
AT (1) | ATE144143T1 (de) |
AU (1) | AU624628B2 (de) |
CA (1) | CA1339240C (de) |
DE (1) | DE68927348T2 (de) |
IL (1) | IL91007A (de) |
WO (1) | WO1990000901A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
US5456924A (en) * | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
EP0362909A3 (de) * | 1988-08-26 | 1990-11-14 | Akzo N.V. | Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern |
CA2035576A1 (en) * | 1990-02-07 | 1991-08-08 | Alexander R. Neurath | Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 hiv-1 |
JPH05506669A (ja) * | 1990-09-25 | 1993-09-30 | ペプテック (ユーケイ) リミテッド | エイズ治療法及びワクチン |
CA2106567A1 (en) * | 1991-03-22 | 1992-09-23 | William V. Williams | Method of modulating mammalian t-cell response |
US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
WO1993004697A1 (en) * | 1991-08-29 | 1993-03-18 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
EP0671947B1 (de) * | 1991-12-02 | 2000-03-08 | The Board Of Regents, The University Of Texas System | Zusammensetzungen zum auslösen cytotoxischer t-lymphozyten gegen viren |
WO1993019775A1 (en) * | 1992-03-31 | 1993-10-14 | Medimmune, Inc. | Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins |
EP0652895B1 (de) * | 1992-07-20 | 1999-08-18 | Duke University | Zusammensetzungen die die hiv replikation inhibieren |
DE4228787A1 (de) * | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
JP3277045B2 (ja) * | 1992-10-06 | 2002-04-22 | デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Hiv−グループのレトロウイルスおよびその使用 |
US5607914A (en) * | 1993-01-13 | 1997-03-04 | Pioneer Hi-Bred International, Inc. | Synthetic antimicrobial peptides |
US5869624A (en) * | 1993-03-26 | 1999-02-09 | Progenics Pharmaceuticals, Inc. | HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6749856B1 (en) | 1997-09-11 | 2004-06-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Mucosal cytotoxic T lymphocyte responses |
BR0108210A (pt) | 2000-02-04 | 2002-10-22 | Univ Duke | Vacina contra o vìrus da imunodeficiência humana |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
CN101146550B (zh) * | 2004-12-29 | 2013-04-17 | 曼康公司 | 免疫原性组合物用于制备引发和增强免疫应答的试剂盒的用途 |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
US20140065601A1 (en) * | 2011-03-23 | 2014-03-06 | Tamar Jehuda-Cohen | Method and kit for estimating human immunodeficiency virus (hiv) incidence |
ES2667425T3 (es) | 2011-06-10 | 2018-05-10 | Oregon Health & Science University | Glucoproteínas y vectores recombinantes de CMV |
EP2568289A3 (de) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
WO2015195812A1 (en) | 2014-06-17 | 2015-12-23 | The Research Foundation For The State University Of New York | Ship inhibition to induce activation of natural killer cells |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63501716A (ja) * | 1985-10-24 | 1988-07-14 | サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ | 合成ペプチドおよびaidsおよびarcの診断ならびにワクチン注射へのその使用 |
DE3787002T2 (de) * | 1986-12-30 | 1993-11-25 | Us Health | Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen. |
EP0400076B1 (de) * | 1988-01-26 | 1996-05-15 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Synthetisches antigen zum bewirken einer anti-hiv-reaktion |
EP0330359A3 (de) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion |
-
1988
- 1988-07-21 US US07/222,684 patent/US5030449A/en not_active Expired - Lifetime
-
1989
- 1989-07-17 IL IL9100789A patent/IL91007A/en not_active IP Right Cessation
- 1989-07-19 AU AU39670/89A patent/AU624628B2/en not_active Ceased
- 1989-07-19 JP JP1508125A patent/JP2676166B2/ja not_active Expired - Fee Related
- 1989-07-19 WO PCT/US1989/003123 patent/WO1990000901A1/en active IP Right Grant
- 1989-07-19 EP EP89908567A patent/EP0429477B1/de not_active Expired - Lifetime
- 1989-07-19 DE DE68927348T patent/DE68927348T2/de not_active Expired - Fee Related
- 1989-07-19 AT AT89908567T patent/ATE144143T1/de not_active IP Right Cessation
- 1989-07-20 CA CA000606251A patent/CA1339240C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU624628B2 (en) | 1992-06-18 |
WO1990000901A1 (en) | 1990-02-08 |
EP0429477A4 (en) | 1991-11-13 |
DE68927348T2 (de) | 1997-02-13 |
CA1339240C (en) | 1997-08-05 |
ATE144143T1 (de) | 1996-11-15 |
JP2676166B2 (ja) | 1997-11-12 |
JPH03504384A (ja) | 1991-09-26 |
EP0429477B1 (de) | 1996-10-16 |
IL91007A (en) | 1995-08-31 |
AU3967089A (en) | 1990-02-19 |
IL91007A0 (en) | 1990-02-09 |
EP0429477A1 (de) | 1991-06-05 |
US5030449A (en) | 1991-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68927348D1 (de) | Künstlicher impfstoff gegen aids-virus | |
EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
PE20040554A1 (es) | Vacunas que comprenden proteinas de fusion | |
DE69333397D1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
GB2255093A (en) | Hiv-1 core protein fragments | |
ES2100240T3 (es) | Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen. | |
WO1989002277A3 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
ITRM920350A1 (it) | Epitopi immunologicamente omologhi di hla e proteine del virus hiv. | |
AU6683400A (en) | Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat | |
ES2143996T3 (es) | Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv. | |
ATE248601T1 (de) | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 | |
HUP0202770A2 (hu) | Humán papillómavírus oltóanyag | |
DK56389D0 (da) | Forhindring og behandling af retroviralt frembragte sygdomme | |
DE69301733D1 (de) | Impfstoffe gegen Metazoen-Parasiten | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
DE69428984T2 (de) | Stimulierung der immunantwort durch virales protein | |
ES2080024B1 (es) | Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos. | |
MX9301736A (es) | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
IT1233419B (it) | Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria | |
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |